Company profile
JAZZ PHARMACEUTICALS PLC
NASDAQ:JAZZBiotechnology: Pharmaceutical Preparations
Drug pipeline (22)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| XYWAV | approved | $471.2M*Q2 2026 | 10 | approved |
| EPIDIOLEX | approved | $292.1MQ2 2026 | 28 | approved |
| ZEPZELCA | approved | $105.8MQ2 2026 | 3 | approved |
| RYLAZE | approved | $99.5MQ2 2026 | 0 | — |
| DEFITELIO | approved | $62.0MQ2 2026 | 0 | — |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (180)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02348632 | phase3 | completed | 2015-05-01 | 2017-12-01 | Jazz Pharmaceuticals | "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" |
| NCT02348619 | phase3 | completed | 2015-05-01 | 2016-11-01 | Jazz Pharmaceuticals | "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" |
| NCT02348593 | phase3 | completed | 2015-05-01 | 2017-02-01 | Jazz Pharmaceuticals | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" |
| NCT02348606 | phase3 | completed | 2015-05-01 | 2016-12-01 | Jazz Pharmaceuticals | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" |
| NCT03037203 | phase2 | completed | 2017-01-01 | 2018-08-01 | Jazz Pharmaceuticals | A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness |
FDA applications (12)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| BLA 761416 | 2024-11-20 | BLA | JAZZ PHARMACEUTICALS IRELAND LIMITED | |||||
Loading… | ||||||||
| BLA 761179 | 2021-06-30 | BLA | JAZZ PHARMACEUTICALS IRELAND LIMITED | |||||
Loading… | ||||||||
| NDA 212690 | 2020-07-21 | NDA | JAZZ PHARMACEUTICALS IRELAND LTD | |||||
Loading… | ||||||||
| NDA 213702 | 2020-06-15 | NDA | JAZZ PHARMACEUTICALS IRELAND LTD | |||||
Loading… | ||||||||
| NDA 210365 | 2018-09-28 | NDA | JAZZ PHARMACEUTICALS RESEARCH UK LTD | |||||
Loading… | ||||||||